泛影葡胺在腹部术后早期肠梗阻诊断和治疗的临床分析

目的：探讨泛影葡胺在腹部手术早期肠梗阻诊断和治疗上的价值。方法：回顾性分析2008年1月-2013年12月本院收治的160例腹部术后早期肠梗阻患者的临床资料,其中使用泛影葡胺治疗的80例患者作为治疗组,未使用泛影葡胺治疗的80例患者作为对照组。观察两组的治疗效果,比较两组第一次排气时间、梗阻缓解时间等指标的差异。结果：对照组保守治疗成功55例,成功率为69%,中转手术25例,手术率为31%;治疗组保守治疗成功72例,成功率90%,中转手术8例,手术率10%。两组在第一次肛门排气时间、梗阻缓解时间及保守治疗成功率上比较差异均有统计学意义（P〈0.01）。结论：口服泛影葡胺是术后早期肠梗阻诊断和治疗上一种安全有效的方法。

Clinical Study of Gastrografin in the Diagnosis and Treatment of Early Postoperative Intestinal Obstruction

Objective：To evaluate the efficacy in the diagnosis and treatment of early postoperative intestinal obstruction.Method：160 patients with early postoperative intestinal obstruction from January 2008 to December 2013 were retrospectively analyzed. The patients（n=80） treated with gastrografin were set up the treatment group, the ones without gastrografin were set up the control group（n=80）. The effect of the two groups was compared. And gastrografin in diagnosis and treatment of early postoperative intestinal obstruction was evaluated.Result：55 cases in the control group were relieved by the conservation treatment, with a success rate of 69%, 25 cases underwent operation, operation rate was 31%; while 72 cases in the treatment group were relieved by conservation treatment, with a success rate of 90%, 8 cases underwent operation,operation rate was 10%.The differences in the anal exhaust time, complete remission time, and success rate of the two groups were statistically significant（P〈0.05）.Conclusion：Gastrografin is safe and effective in the diagnosis and treatment of early postoperative intestinal obstruction.